New Collaboration Gives Veterans Better Access To Innovative Research Trials

Cohen Veterans Bioscience announced it is extending its commitment to the brain health of Veterans by supporting the National Association of Veterans Research Education Foundation (NAVREF) and the new VA Office of Research and Development (ORD) led Partnered Research Program (PRP).

NAVREF and VA Partnership Helps Propel COVID-19 Trial in Less Than a Week

As an outcome of the Access to Clinical Trials (ACT) for Veterans initiative, the PRP increases veterans’ access to high-quality clinical trials and streamlines the start-up of new, innovative trials to give Veterans access to world-class health solutions. By improving infrastructure, the PRP is helping agencies and organizations to partner more rapidly on critical research trials, specifically targeting the enhanced inclusion of Veterans.

“With critical support from our Champion Circle sponsor, Cohen Veterans Bioscience, and other partners, we have helped establish a program with VA ORD where dedicated facilitators will interface with industry sponsors and coordinate with VA-affiliated non-profit research corporations (NPCs) and VA medical center research services,” says Rick Starrs, CEO, NAVREF. “Moving forward, this will expedite study start-up and the evaluation of a new generation of therapeutics for our Veterans and other patients.”

One example of the effectiveness of the launch of the PRP is that it allowed the National Institute of Allergy and Infectious Diseases (NIAID) to partner with the VA on its COVID-19 trial, which was rapidly activated in under a week.

“Veterans have made many sacrifices for our country and deserve access to best-in-class healthcare. In a short time, the new Partnered Research Program has already demonstrated that it can enhance the VA’s research capacity and position the VA as a leading clinical studies partner,” says Magali Haas, MD, PhD, CEO of CVB. “A testament to this accelerated implementation is the VA’s new partnership with NIAID on a critically important COVID-19 trial.”

As architects of the PRP, NAVREF and ORD will help streamline start-up activities and provide other efficiencies for VA multi-site clinical trials. In doing so, they hope to encourage more industry sponsors and enable Veterans to participate in clinical trials to give them access to new therapeutic interventions.

View this press release on PRNewswire

About the National Association of Veterans’ Research and Education Foundations (NAVREF)

Formed in 1992, the National Association of Veterans’ Research and Education Foundations (NAVREF) is the 501(c)(3) nonprofit membership organization of research and education foundations affiliated with Department of Veterans Affairs (VA) medical centers. These nonprofits, also known as the VA-affiliated nonprofit research and education corporations (NPCs), are authorized by Congress under 38 USC §§7361-7366 to provide flexible funding mechanisms for the conduct of research and education at VA facilities nationwide. 

Share this article:

More from CVB

Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder

New meta-analysis builds upon PTSD genetics research, providing a foundation for the development of precision therapies

Driving Progress: TBI Action Alliance Launches Multi-Pronged Initiative to Speed Development of Diagnostic and Therapeutic Solutions for Traumatic Brain Injury

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.

For Media Inquiries

Please feel free to email us at